🚀

REGN Regeneron Pharmaceuticals Inc

Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Biotechnology > Biotechnology  | NASDAQ, LargeCap, BiotechHealthcare |  Last Price: 781.67 | 2026-02-27 | Atrp: 2.85

Sat 21 Feb 2026 to Fri 27 Feb 2026: Score 16

MetricPreviousNewChangeInterpretation
✅PEG Ratio1.52751.154▼ -24.45%Bullish. Lower is better. Significant decrease, improving the value relative to growth
P/E ratio adjusted for growth rate
✅Forward PE18.248215.456▼ -15.3%Bullish. Lower is better. Moderate improvement
Stock price divided by expected future earnings
✅Price Book MRQ2.71662.1241▼ -21.81%Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception
Stock price divided by book value per share for the most recent quarter
✅Enterprise Value/Revenue5.50884.1387▼ -24.87%Bullish. Lower is better. Significant improvement
Enterprise value divided by revenue
✅Enterprise Value/EBITDA13.580110.8509▼ -20.1%Bullish. Lower is better. Significant improvement
Enterprise value to earnings before interest, taxes, depreciation
✅Short Ratio2.492.33▼ -6.43%Bullish. Lower is better. Slight improvement
✅Short Percent2.17%2.05%▼ -5.53%Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
✅Price Sales TTM5.74695.6814▼ -1.14%Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Enterprise Value$79.01B$58.83B▼ -25.55%Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments
Market capitalization plus debt minus cash

Sat 14 Feb 2026 to Sat 21 Feb 2026: Score -2

MetricPreviousNewChangeInterpretation
❌PEG Ratio1.49041.5275▲ 2.49%Bearish. Lower is better. Slight increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Forward PE17.825318.2482▲ 2.37%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings
❌Price Book MRQ2.65052.7166▲ 2.49%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌Enterprise Value/Revenue5.36495.5088▲ 2.68%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue
❌Enterprise Value/EBITDA13.225413.5801▲ 2.68%Bearish. Lower is better. Slight decline
Enterprise value to earnings before interest, taxes, depreciation
✅Price Sales TTM5.92015.7469▼ -2.93%Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
✅Enterprise Value$76.95B$79.01B▲ 2.68%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash
✅Institutional Ownership89.459%90.905%▲ 1.62%Bullish. Higher is better. Slight increase; continued strong interest from big investors
Percentage held by institutions like mutual funds

Sat 07 Feb 2026 to Sat 14 Feb 2026: Score -1

MetricPreviousNewChangeInterpretation
❌PEG Ratio1.4581.4904▲ 2.22%Bearish. Lower is better. Slight increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Forward PE17.421617.8253▲ 2.32%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings
❌Price Sales TTM5.78995.9201▲ 2.25%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Price Book MRQ2.5932.6505▲ 2.22%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌Enterprise Value/Revenue5.23945.3649▲ 2.4%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue
❌Enterprise Value/EBITDA12.916113.2254▲ 2.39%Bearish. Lower is better. Slight decline
Enterprise value to earnings before interest, taxes, depreciation
✅Enterprise Value$75.15B$76.95B▲ 2.39%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash
✅Short Ratio2.742.49▼ -9.12%Bullish. Lower is better. Slight improvement
✅Short Percent2.3%2.17%▼ -5.65%Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short

Sat 31 Jan 2026 to Sat 07 Feb 2026: Score -18

MetricPreviousNewChangeInterpretation
❌Quarterly Earnings Growth YOY181%-31%▼ -114.44%Bearish. Higher is better. Quarterly earnings growth YOY turned from growth to decline; signs of deterioration.
Year-over-year growth in quarterly earnings
❌Operating Margin TTM29.56%23.13%▼ -21.75%Bearish. Higher is better. Operating margin TTM growth slowing.
Percentage of revenue left after operating expenses
❌Enterprise Value/Revenue4.30645.2394▲ 21.67%Bearish. Lower is better. Significant decline
Enterprise value divided by revenue
❌Enterprise Value/EBITDA11.710312.9161▲ 10.3%Bearish. Lower is better. Moderate decline
Enterprise value to earnings before interest, taxes, depreciation
❌EPS Estimate Current Year48.208644.5565▼ -7.58%Bearish. Higher is better. Slight decrease; reduced outlook for current year earnings
Expected earnings per share this year
❌Return On Assets TTM6.16%5.91%▼ -4.06%Bearish. Higher is better. Return on assets TTM growth slowing.
Efficiency in generating profits from total assets
❌Price Sales TTM5.51555.7899▲ 4.98%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Price Book MRQ2.49312.593▲ 4.01%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌EBITDA$4348M$4245.7M▼ -2.35%Bearish. Higher is better. Decline in earnings before interest, taxes, depreciation, and amortization; indicates weaker operational cash flow
Earnings before interest, taxes, depreciation, and amortization
❌PEG Ratio1.41011.458▲ 3.4%Bearish. Lower is better. Slight increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Profit Margin32.13%31.41%▼ -2.24%Bearish. Higher is better. Profit margin growth slowing.
Percentage of revenue that turns into profit
❌Return On Equity TTM15.19%14.86%▼ -2.17%Bearish. Higher is better. Return on equity TTM growth slowing.
Efficiency in generating profits from shareholders' equity
❌Gross Profit TTM$6530.1M$6392M▼ -2.11%Bearish. Higher is better. Slight decline, but margins may be holding
Revenue minus cost of goods sold over the trailing twelve months
❌Forward PE16.863417.4216▲ 3.31%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings
✅Wall Street Target Price842.4231859.5769▲ 2.04%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅Book Value301.146304.648▲ 1.16%Bullish. Higher is better. Slight increase; stock now trades closer to book value
Net asset value of the company per share
✅Revenue Per Share TTM134.763137.121▲ 1.75%Bullish. Higher is better. Slight improvement
Revenue generated per outstanding share over the trailing twelve months
✅Enterprise Value$73.03B$75.15B▲ 2.9%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash
✅Quarterly Revenue Growth YOY11%31%▲ 177.78%Bullish. Higher is better. Quarterly revenue growth YOY growth accelerating.
Year-over-year growth in quarterly revenue

Sat 24 Jan 2026 to Sat 31 Jan 2026: Score 19

MetricPreviousNewChangeInterpretation
✅EPS Estimate Current Year43.15848.2086▲ 11.7%Bullish. Higher is better. Moderate increase; improved outlook for current year earnings
Expected earnings per share this year
✅EPS Estimate Next Year39.555246.9471▲ 18.69%Bullish. Higher is better. Moderate raised expectations for further out
Expected earnings per share next year
✅Enterprise Value/Revenue5.15594.3064▼ -16.48%Bullish. Lower is better. Moderate improvement
Enterprise value divided by revenue
✅Enterprise Value/EBITDA12.859911.7103▼ -8.94%Bullish. Lower is better. Slight improvement
Enterprise value to earnings before interest, taxes, depreciation
✅Short Percent2.5%2.3%▼ -8%Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
✅PEG Ratio1.43311.4101▼ -1.6%Bullish. Lower is better. Slight decrease, improving the value relative to growth
P/E ratio adjusted for growth rate
✅Wall Street Target Price830.0385842.4231▲ 1.49%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅Forward PE17.123316.8634▼ -1.52%Bullish. Lower is better. Slight improvement
Stock price divided by expected future earnings
✅Price Sales TTM5.60565.5155▼ -1.61%Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
✅Price Book MRQ2.55822.4931▼ -2.54%Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception
Stock price divided by book value per share for the most recent quarter
✅Short Ratio2.842.74▼ -3.52%Bullish. Lower is better. Slight improvement

Sat 17 Jan 2026 to Sat 24 Jan 2026: Score -5

MetricPreviousNewChangeInterpretation
❌PEG Ratio1.39411.4331▲ 2.8%Bearish. Lower is better. Slight increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Forward PE16.666717.1233▲ 2.74%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings
❌Price Sales TTM5.4535.6056▲ 2.8%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Price Book MRQ2.48862.5582▲ 2.8%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌Enterprise Value/Revenue5.00465.1559▲ 3.02%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue
❌Enterprise Value/EBITDA12.482512.8599▲ 3.02%Bearish. Lower is better. Slight decline
Enterprise value to earnings before interest, taxes, depreciation
✅Enterprise Value$71.3B$73.46B▲ 3.02%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash

Sat 10 Jan 2026 to Sat 17 Jan 2026: Score 11

MetricPreviousNewChangeInterpretation
✅PEG Ratio1.56231.3941▼ -10.77%Bullish. Lower is better. Moderate decrease, improving the value relative to growth
P/E ratio adjusted for growth rate
✅Forward PE18.656716.6667▼ -10.67%Bullish. Lower is better. Moderate improvement
Stock price divided by expected future earnings
✅Price Sales TTM5.92545.453▼ -7.97%Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
✅Price Book MRQ2.71942.4886▼ -8.49%Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception
Stock price divided by book value per share for the most recent quarter
✅Enterprise Value/Revenue5.50595.0046▼ -9.1%Bullish. Lower is better. Slight improvement
Enterprise value divided by revenue
✅Enterprise Value/EBITDA13.733112.4825▼ -9.11%Bullish. Lower is better. Slight improvement
Enterprise value to earnings before interest, taxes, depreciation
✅Short Percent2.75%2.5%▼ -9.09%Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
❌Enterprise Value$78.45B$71.3B▼ -9.11%Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments
Market capitalization plus debt minus cash
❌Short Ratio2.422.84▲ 17.36%Bearish. Lower is better. Moderate decline

Sat 03 Jan 2026 to Sat 10 Jan 2026: Score -4

MetricPreviousNewChangeInterpretation
❌Enterprise Value/Revenue5.2915.5059▲ 4.06%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue
❌Enterprise Value/EBITDA13.19713.7331▲ 4.06%Bearish. Lower is better. Slight decline
Enterprise value to earnings before interest, taxes, depreciation
❌PEG Ratio1.52161.5623▲ 2.67%Bearish. Lower is better. Slight increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Forward PE18.181818.6567▲ 2.61%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings
❌Price Sales TTM5.77495.9254▲ 2.61%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Price Book MRQ2.62042.7194▲ 3.78%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
✅Wall Street Target Price797.2692824.6923▲ 3.44%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅EPS Estimate Next Year38.776339.533▲ 1.95%Bullish. Higher is better. Slight raised expectations for further out
Expected earnings per share next year
✅Enterprise Value$75.39B$78.45B▲ 4.06%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash

Sun 21 Dec 2025 to Sat 03 Jan 2026: Score 5

MetricPreviousNewChangeInterpretation
✅Short Percent3.16%2.75%▼ -12.97%Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
✅Short Ratio2.662.42▼ -9.02%Bullish. Lower is better. Slight improvement
✅EPS Estimate Next Year38.356338.7763▲ 1.09%Bullish. Higher is better. Slight raised expectations for further out
Expected earnings per share next year
❌Price Sales TTM5.71285.7749▲ 1.09%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months